Skip to main content

Advocacy News

News and views on the regulatory, legislative, and political issues impacting ophthalmology in Washington, D.C., and around the United States

Image
Ophthalmologist Raj Maturi, MD, with a patient in his clinic.
Member exclusive - Locked
Featured News

The Centers for Medicare & Medicaid Services (CMS) has released its proposed Medicare Physician Fee Schedule for 2027. Here are the highlights based on the Academy’s analysis. The Academy will work with our advocacy partners to ensure finalized policies support our members and their patients.

Read the Story
Filters
Advocacy Issues
Member exclusive - Locked
May 14, 2025
White House Issues Executive Order on Lowering Drug Prices

The order could tie U.S. prices to the lowest price paid by a select number of developed countries.

Member exclusive - Locked
May 1, 2025
West Virginia Optometric Scope Bill Becomes Law

A bill expanding optometric scope in West Virginia automatically became law on May 2 when Gov. Patrick Morrisey opted to neither sign nor veto this risk to patient safety.

Member exclusive - Locked
April 9, 2025
Minnesota Optometrists Seek Prescription Privileges

Stay updated with the latest information on threats to quality eye care in Minnesota.

Member exclusive - Locked
March 19, 2025
Vision Screening Resolution Advances in Georgia House of Representatives

Georgia House lawmakers passed a nonbinding resolution urging the state’s Departments of Education and Public Health to work together to establish vision and hearing screening programs for school-aged children.

Image
Safe eye surgery is under attack in 15 states
Member exclusive - Locked
March 12, 2025
Record Wave of Optometric Surgery Bills Threatens Patient Safety in 2025 

There are more scope bills being considered than ever before, many allowing optometrists to perform surgery after a mere 32-hour training course.  

Member exclusive - Locked
February 19, 2025
Academy, ASRS Fight Dual Administration Claim Denials

We acted following member reports of claim denials for dual administration of geographic atrophy and anti-vascular endothelial growth factor drugs.

Image
A closeup photo of a doctor's hands wearing blue latex gloves as he pulls medicine from a small bottle with a syringe
Member exclusive - Locked
November 13, 2024
Ophthalmology Calls for Step Therapy Pause for Repackaged Avastin During Supply Chain Disruption

CMS signaled a willingness to review the request in its Nov. 12 meeting with the Academy and the American Society of Retina Specialists.

Member exclusive - Locked
October 30, 2024
Academy Urges Insurers to Suspend Step Therapy Due to Potential Avastin Supply Issues

The Academy urged large commercial insurers and Medicare Advantage plans to suspend anti-VEGF step therapy requirements in response to Pine Pharmaceuticals discontinuation of repackaged Avastin (bevacizumab).

Image
A closeup photo of a doctor's hands wearing blue latex gloves as he pulls medicine from a small bottle with a syringe
Member exclusive - Locked
October 14, 2024
Pine Pharmaceuticals Discontinues Avastin and Other Ophthalmic Product Manufacturing

The Academy is engaging with alternative suppliers and pushing CMS to intervene on Medicare Advantage plan step therapy requirements for Avastin. 

Member exclusive - Locked
March 13, 2024
Quality Eye Care Wins in West Virginia

When the state’s legislative session ended on March 9, a proposal to expand optometric surgery and a proposal to mandate costly pediatric eye exams died in the respective committees without a vote, thanks to the tireless work of the West Virginia Academy of Eye Physicians and Surgeons to connect with and educate state legislators.